Weibel-palade bodies: Vesicular trafficking on the vascular highways

Endothelial Biomedicine

Volumn , Issue , 2007, Pages 657-663

  Lowenstein, Charles J ^a   Morrell, Craig N ^a   Yamakuchi, Munekazu ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 57049187218     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511546198.073     Document Type: Chapter

References (66)

1. Weibel ER, Palade GE. New cytoplasmic components in arterial endothelia. J Cell Biol. 1964;23:101–112.
2. Wagner DD, Olmsted JB, Marder VJ. Immunolocalization of von Willebrand protein inWeibel-Palade bodies of human endothelial cells. J Cell Biol. 1982;95(1):355–360.
3. Wagner DD, Mayadas T, Marder VJ. Initial glycosylation and acidicpHin the Golgi apparatus are required formultimerization of vonWillebrand factor. J Cell Biol. 1986;102(4):1320–1324.
4. Wagner DD, Saffaripour S, Bonfanti R, et al. Induction of specific storage organelles by vonWillebrand factor propolypeptide. Cell. 1991;64(2):403–413.
5. Levy GG, Motto DG, Ginsburg D. ADAMTS13 Turns 3. Blood. 2005;106(1):11–17.
6. Ruggeri ZM. Platelets in atherothrombosis. Nat Med. 2002;8(11): 1227–1234.
7. Denis C, Methia N, Frenette PS, et al. A mouse model of severe von Willebrand disease: defects in hemostasis and thrombosis. Proc Natl Acad Sci USA. 1998;95(16):9524–9529.
8. Huber D, Cramer EM, Kaufmann JE, et al. Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo. Blood. 2002; 99(10):3637–3645.
9. Padilla A, Moake JL, Bernardo A, et al. P-selectin anchors newly released ultralarge von Willebrand factor multimers to the endothelial cell surface. Blood. 2004;103(6):2150–2156.
10. Dong JF, Moake JL, Nolasco L, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100(12):4033–4039.
11. Bonfanti R, Furie BC, Furie B, Wagner DD. PADGEM(GMP140) is a component of Weibel-Palade bodies of human endothelial cells. Blood. 1989;73(5):1109–1112.
12. Mc Ever RP, Beckstead JH, Moore KL, et al. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 1989;84(1):92–99.
13. Subramaniam M, Koedam JA,Wagner DD. Divergent fates of Pand E-selectins after their expression on the plasma membrane. Mol Biol Cell. 1993;4(8):791–801.
14. Mayadas TN, Johnson RC, Rayburn H, et al. Leukocyte rolling and extravasation are severely compromised in P selectindeficient mice. Cell. 1993;74(3):541–554.
15. Wolff B, Burns AR, Middleton J, Rot A. Endothelial cell “memory” of inflammatory stimulation: human venular endothelial cells store interleukin 8 inWeibel-Palade bodies. J ExpMed. 1998; 188(9):1757–1762.
16. Utgaard JO, Jahnsen FL, Bakka A, et al. Rapid secretion of prestored interleukin 8 fromWeibel-Palade bodies of microvascular endothelial cells. J Exp Med. 1998;188(9):1751–1756.
17. Vischer UM,Wagner DD. CD63is a component ofWeibel-Palade bodies of human endothelial cells. Blood. 1993;82(4):1184–1191.
18. Coppinger JA,Cagney G, Toomey S, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004;103(6):2096–2104.
19. Journet AM, Saffaripour S, Cramer EM, et al. von Willebrand factor storage requires intact prosequence cleavage site. Eur J Cell Biol. 1993;60(1):31–41.
20. Voorberg J, Fontijn R, Calafat J, et al. Biogenesis of von Willebrand factor-containing organelles in heterologous transfected CV-1 cells. EMBO J. 1993;12(2):749–758.
21. Haberichter SL, Fahs SA, Montgomery RR. vonWillebrandfactor storage and multimerization: 2 independent intracellular processes. Blood. 2000;96(5):1808–1815.
22. Haberichter SL, Jacobi P, Montgomery RR. Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage. Blood. 2003;101(4):1384–1391.
23. Haberichter SL, Jozwiak MA, Rosenberg JB, et al. The vonWillebrand factor propeptide (VWFpp) traffics an unrelated protein to storage. Arterioscler Thromb Vasc Biol. 2002;22(6):921–926.
24. Haberichter SL, Merricks EP, Fahs SA, et al. Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells. Blood. 2005;105(1):145–152.
25. Barlowe C. Molecular recognition of cargo by the COPII complex: a most accommodating coat. Cell. 2003;114(4):395–397.
26. Miller EA, Beilharz TH, Malkus PN, et al. Multiple cargo binding sites on the COPII subunit Sec24p ensure capture of diverse membrane proteins into transport vesicles. Cell. 2003;114(4): 497–509.
27. Mossessova E, Bickford LC, Goldberg J. SNARE selectivity of the COPII coat. Cell. 2003;114(4):483–495.
28. Denis CV, Andre P, Saffaripour S, Wagner DD. Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci USA. 2001;98(7):4072–4077.
29. Hoyer LW, De los Santos RP, Hoyer JR. Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy. J Clin Invest. 1973;52(11):2737–2744.
30. Rondaij MG, Bierings R, Kragt A, et al. Dynein-dynactin complex mediates protein kinase A-dependent clustering ofWeibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol. 2006;26(1):49–55.
31. Sporn LA, Marder VJ, Wagner DD. Differing polarity of the constitutive and regulated secretory pathways for von Willebrand factor in endothelial cells. J Cell Biol. 1989;108(4):1283–1289.
32. Qian Z, Gelzer-Bell R, Yang SX, et al. Inducible nitric oxide synthase inhibition of Weibel-Palade body release in cardiac transplant rejection. Circulation. 2001;104(19):2369–2375.
33. Mellman I, Warren G. The road taken: past and future foundations of membrane traffic. Cell. 2000;100(1):99–112.
34. Jahn R, Sudhof TC. Membrane fusion and exocytosis. Annu Rev Biochem. 1999;68:863–911.
35. Jahn R, Lang T, Sudhof TC. Membrane fusion. Cell. 2003;112(4): 519–533.
36. Jahn R. Principles of exocytosis and membrane fusion. Ann NY Acad Sci. 2004;1014:170–178.
37. Rondaij MG, Sellink E, Gijzen KA, et al. Small GTP-binding protein Ral is involved in cAMP-mediated release of von Willebrand factor fromendothelial cells. Arterioscler ThrombVasc Biol. 2004;24(7):1315–1320.
38. de Leeuw HP, Fernandez-Borja M, Reits EA, et al. Small GTPbinding protein Ral modulates regulated exocytosis of vonWillebrand factor by endothelial cells. Arterioscler Thromb Vasc Biol. 2001;21(6):899–904.
39. De Leeuw HP, Wijers-Koster PM, van Mourik JA, Voorberg J. Small GTP-binding protein RalA associates with Weibel-Palade bodies in endothelial cells. Thromb Haemost. 1999;82(3):1177–1181.
40. Hannah MJ, Hume AN, Arribas M, et al. Weibel-Palade bodies recruit Rab27 by a content-driven, maturation-dependent mechanism that is independent of cell type. J Cell Sci. 2003;116 (Pt 19):3939–3948.
41. Matsushita K, Morrell CN, Cambien B, et al. Nitric oxide regulates exocytosis by S-nitrosylation of N-ethylmaleimide-sensitive factor. Cell. 2003;115(2):139–150.
42. Fu J, Naren AP, Gao X, et al. Protease-activated receptor-1 activation of endothelial cells induces protein kinase Calphadependent phosphorylation of syntaxin 4 and Munc18c: role in signaling p-selectin expression. J Biol Chem. 2005;280(5):3178–3184.
43. Fayos BE, Wattenberg BW. Regulated exocytosis in vascular endothelial cells can be triggered by intracellular guanine nucleotides and requires a hydrophobic, thiol-sensitive component. Studies of regulated von Willebrand factor secretion from digitonin permeabilized endothelial cells. Endothelium. 1997;5(4): 339–350.
44. Malhotra V, Orci L, Glick BS, et al. Role of an N-ethylmaleimidesensitive transport component in promoting fusion of transport vesicles with cisternae of the Golgi stack. Cell. 1988;54(2):221–227.
45. Block MR, Glick BS, Wilcox CA, et al. Purification of an Nethylmaleimide-sensitive protein catalyzing vesicular transport. Proc Natl Acad Sci USA. 1988;85(21):7852–7856.
46. Whiteheart SW, Rossnagel K, Buhrow SA, et al. Nethylmaleimide-sensitive fusion protein: a trimeric ATPase whose hydrolysis of ATP is required for membrane fusion. J Cell Biol. 1994;126(4):945–954.
47. Whiteheart SW, Schraw T, Matveeva EA. N-ethylmaleimide sensitive factor (NSF) structure and function. Int Rev Cytol. 2001; 207:71–112.
48. Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation. 1990;50(4):537–544.
49. Sporn LA, Marder VJ, Wagner DD. Inducible secretion of large, biologically potent vonWillebrand factormultimers. Cell. 1986; 46(2):185–190.
50. Pinsky DJ, Naka Y, Liao H, et al. Hypoxia-induced exocytosis of endothelial cellWeibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest. 1996;97(2):493–500.
51. Shreeniwas R, Koga S, Karakurum M, et al. Hypoxia-mediated induction of endothelial cell interleukin-1 alpha. An autocrine mechanism promoting expression of leukocyte adhesion molecules on the vessel surface. J Clin Invest. 1992;90(6):2333–2339.
52. Zizzi HC, Zibari GB, Granger DN, et al. Quantification of Pselectin expression after renal ischemia and reperfusion. J Pediatr Surg. 1997;32(7):1010–1013.
53. Yamada S, Mayadas TN, Yuan F, et al. Rolling in P-selectindeficient mice is reduced but not eliminated in the dorsal skin. Blood. 1995; 86(9): 3487–3492.
54. Hallahan DE, Virudachalam S. Ionizing radiation mediates expression of cell adhesion molecules in distinct histological patterns within the lung. Cancer Res. 1997;57(11):2096–2099.
55. Hallahan DE, Staba-Hogan MJ, Virudachalam S, Kolchinsky A. X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Res. 1998;58(22):5216–5220.
56. Hallahan DE, Virudachalam S. Accumulation of P-selectin in the lumen of irradiated blood vessels. Radiat Res. 1999;152(1):6–13.
57. Reidy MA, Chopek M, Chao S, et al. Injury induces increase of von Willebrand factor in rat endothelial cells. Am J Pathol. 1989;134(4):857–864.
58. Vischer UM, Wollheim CB. Purine nucleotides induce regulated secretion of vonWillebrand factor: involvement of cytosolic Ca2+ and cyclic adenosinemonophosphate-dependent signaling in endothelial exocytosis. Blood. 1998;91(1):118–127.
59. Palmer DS, Aye MT, Ganz PR, et al. Adenosine nucleotides and serotonin stimulate vonWillebrand factor release from cultured human endothelial cells. Thromb Haemost. 1994;72(1):132–139.
60. Vischer UM, Barth H, Wollheim CB. Regulated vonWillebrand factor secretion is associated with agonist-specific patterns of cytoskeletal remodeling in cultured endothelial cells. Arterioscler Thromb Vasc Biol. 2000;20(3):883–891.
61. Schluter T, Bohnensack R. Serotonin-induced secretion of von Willebrand factor from human umbilical vein endothelial cells via the cyclic AMP-signaling systems independent of increased cytoplasmic calcium concentration. Biochem Pharmacol. 1999;57(10):1191–1197.
62. Kagawa H, Fujimoto S. Electron-microscopic and immunocytochemical analyses ofWeibel-Palade bodies in the human umbilical vein during pregnancy. Cell Tissue Res. 1987; 249(3):557–563.
63. Ribes JA, Francis CW, Wagner DD. Fibrin induces release of vonWillebrand factor from endothelial cells. J Clin Invest. 1987; 79(1):117–123.
64. Ota H, Fox-Talbot K, Hu W, et al. Terminal complement components mediate release of von Willebrand factor and adhesion of platelets in arteries of allografts. Transplantation. 2005;79(3): 276–281.
65. Matsushita K, Yamakuchi M, Morrell CN, et al. Vascular endothelial growth factor regulation of Weibel-Palade-body exocytosis. Blood. 2005;105(1):207–214.
66. Iafrati MD, Vitseva O, Tanriverdi K, et al. Compensatory mechanisms influence hemostasis in the setting of eNOS-deficiency. Am J Physiol Heart Circ Physiol. 2005;288(4):H1627–1632.